IS7868A - Notkun á kortkólíberín-úrókortín kerfi í meðferð á bólguvaldandi sjúkdómum. - Google Patents

Notkun á kortkólíberín-úrókortín kerfi í meðferð á bólguvaldandi sjúkdómum.

Info

Publication number
IS7868A
IS7868A IS7868A IS7868A IS7868A IS 7868 A IS7868 A IS 7868A IS 7868 A IS7868 A IS 7868A IS 7868 A IS7868 A IS 7868A IS 7868 A IS7868 A IS 7868A
Authority
IS
Iceland
Prior art keywords
corticoliberin
urocortin
treatment
inflammatory diseases
inflammatory
Prior art date
Application number
IS7868A
Other languages
English (en)
Inventor
N. Margioris Andrew
Gravanis Achille
Original Assignee
Bionature E.A. Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bionature E.A. Limited filed Critical Bionature E.A. Limited
Publication of IS7868A publication Critical patent/IS7868A/is

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Neurology (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Zoology (AREA)
  • Pain & Pain Management (AREA)
  • Neurosurgery (AREA)
  • Endocrinology (AREA)
  • Biomedical Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Peptides Or Proteins (AREA)
IS7868A 2002-11-26 2005-05-26 Notkun á kortkólíberín-úrókortín kerfi í meðferð á bólguvaldandi sjúkdómum. IS7868A (is)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GR20020100513A GR1004664B (en) 2002-11-26 2002-11-26 The charakteristics and advantages of our invention are illustrated by the following description, methods and results of our research, attached figures and supporting references
PCT/IB2003/005429 WO2004047866A2 (en) 2002-11-26 2003-11-26 Use of the corticoliberin-urocortin system in the treatment of inflammatory diseases

Publications (1)

Publication Number Publication Date
IS7868A true IS7868A (is) 2005-05-26

Family

ID=36441288

Family Applications (1)

Application Number Title Priority Date Filing Date
IS7868A IS7868A (is) 2002-11-26 2005-05-26 Notkun á kortkólíberín-úrókortín kerfi í meðferð á bólguvaldandi sjúkdómum.

Country Status (15)

Country Link
US (2) US20060135417A1 (is)
EP (1) EP1565215A2 (is)
JP (1) JP2006509756A (is)
KR (1) KR20050085167A (is)
CN (1) CN1756566A (is)
AU (1) AU2003302368B2 (is)
BR (1) BR0316638A (is)
CA (1) CA2506607A1 (is)
GR (1) GR1004664B (is)
HR (1) HRP20050484A2 (is)
IS (1) IS7868A (is)
MX (1) MXPA05005617A (is)
NZ (1) NZ540455A (is)
PL (1) PL378271A1 (is)
WO (1) WO2004047866A2 (is)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2187935A2 (en) * 2007-09-11 2010-05-26 Mondobiotech Laboratories AG Use of the peptide his-ser-leu-gly-lys-trp-leu-gly-his-pro-asp-lys-phe alone or in combination with the peptide pro-gly-thr-cys-glu-ile-cys-ala-tyr-ala-ala-cys-thr-gly-cys-oh as a therapeutic agent
WO2010013086A1 (en) * 2008-08-01 2010-02-04 Centre National De La Recherche Scientifique Phosphorylated dendrimers as antiinflammatory drugs
GB201210686D0 (en) 2012-06-15 2012-08-01 Holsboermaschmeyer Neurochemie Gmbh V1B receptor antagonist for use in the treatment of patients having an elevated AVP level and/or an elevated copeptin level
GB201310782D0 (en) 2013-06-17 2013-07-31 Max Planck Innovation Gmbh Method for predicting a treatment response to a CRHR1 antagonist and/or V1B antagonist in a patient with depressive and/or anxiety symptoms
JOP20170153A1 (ar) 2016-07-15 2019-01-30 Lilly Co Eli نظائر urocortin-2 جديدة معدلة بحمض دهني لعلاج داء السكري وأمراض الكلى المزمنة
US10729693B2 (en) * 2018-03-02 2020-08-04 Ponce Medical School Foundation, Inc. Compositions and methods for the treatment of endometriosis

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994013676A1 (en) * 1992-12-17 1994-06-23 Pfizer Inc. Pyrrolopyrimidines as crf antagonists
US20020082409A1 (en) * 2000-10-26 2002-06-27 Hsu Sheau Yu Stresscopins and their uses

Also Published As

Publication number Publication date
WO2004047866A2 (en) 2004-06-10
US20090247558A1 (en) 2009-10-01
AU2003302368A1 (en) 2004-06-18
BR0316638A (pt) 2005-10-11
CA2506607A1 (en) 2004-06-10
GR20020100513A (el) 2004-07-19
HRP20050484A2 (en) 2005-12-31
PL378271A1 (pl) 2006-03-20
WO2004047866A3 (en) 2004-07-29
JP2006509756A (ja) 2006-03-23
NZ540455A (en) 2007-05-31
KR20050085167A (ko) 2005-08-29
EP1565215A2 (en) 2005-08-24
US20060135417A1 (en) 2006-06-22
CN1756566A (zh) 2006-04-05
AU2003302368B2 (en) 2007-10-11
MXPA05005617A (es) 2005-11-23
GR1004664B (en) 2004-09-02

Similar Documents

Publication Publication Date Title
IS7814A (is) Fenetanólamín afleiða í meðhöndlun á öndunarfærasjúkdómum.
DK1342881T3 (da) Opskummet syrebehandlingsvæske
NL1024643A1 (nl) Purineverbindingen en gebruik daarvan.
IS7738A (is) Þíasól efnasambönd til notkunar í meðferð á taugahrörnunar truflunum.
DE60331027D1 (de) tsprechendes System
DE60239766D1 (de) Wärmebehandlungssystem
IS7444A (is) Morfólínýl-þvagefna afleiður til notkunar við meðhöndlun á bólguvaldandi sjúkdómum
NO20050689L (no) Terapeutisk anvendelse
IS7825A (is) Meðferðarfræðileg meðhöndlun
DE60301239D1 (de) Verbinder
ATE326467T1 (de) Imidazo 1,2-aöpyridine
IS7868A (is) Notkun á kortkólíberín-úrókortín kerfi í meðferð á bólguvaldandi sjúkdómum.
IS7163A (is) Aðferðir til meðhöndlunar á lungnasjúkdómi
DK1597171T3 (da) Terapeutisk mikroskum
DE60312105D1 (de) Verbinder
DE60218623D1 (de) Verbinder
EG24959A (en) Indoles useful in the treatment of androgenreceptor related diseases.
DK1496918T3 (da) Anvendelse af natriummetaarsenit til behandling af tumorer
NO20053189D0 (no) HVC-kombinasjonsterapi.
FR2837224B1 (fr) Bonde traitante
DE60229887D1 (de) Oberflächenbehandlungssystem
DE60311724D1 (de) Verbinder
IS7537A (is) Notkun á nýjum etónógestrel esterum.
IS8391A (is) Notkun á síramesíni við meðhöndlun á krabbameini
NO20022747D0 (no) Behandlingsstol